Valuation Sun Pharmaceutical Industries Ltd.

Equities

Delayed NSE India S.E. Other stock markets 04:40:35 2026-01-20 am EST			5-day change	1st Jan Change
1,613.60 ^INR	-3.69%		-6.92%	-6.04%

Jan. 19	Sun Pharma states Organon acquisition news is speculative	RE
Jan. 15	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	1,434,322	2,194,737	2,358,729	3,888,242	4,162,126	4,019,846	-	-
Change	-	53.02%	7.47%	64.84%	7.04%	-3.42%	-	-
Enterprise Value (EV) ¹	1,363,238	2,077,371	2,269,278	3,725,634	3,930,920	3,793,852	3,717,291	3,622,382
Change	-	52.39%	9.24%	64.18%	5.51%	-3.49%	-2.02%	-2.55%
P/E ratio	49.4x	67.3x	27.8x	40.6x	38x	35.8x	30.2x	26.4x
PBR	3.09x	4.57x	4.21x	6.11x	5.76x	5x	4.45x	3.98x
PEG	-	5.4x	0x	3.1x	2.7x	14.06x	1.6x	1.9x
Capitalization / Revenue	4.28x	5.68x	5.37x	8.02x	7.92x	7x	6.33x	5.71x
EV / Revenue	4.07x	5.37x	5.17x	7.68x	7.48x	6.61x	5.85x	5.15x
EV / EBITDA	16.1x	20x	19.5x	28.7x	26.1x	23.2x	20x	17.2x
EV / EBIT	21.3x	25.2x	24.9x	35.7x	31.4x	27.9x	23.7x	20x
EV / FCF	27.3x	27.7x	79x	37.5x	32.9x	51.3x	32.3x	27.1x
FCF Yield	3.67%	3.61%	1.27%	2.67%	3.04%	1.95%	3.1%	3.69%
Dividend per Share ²	7.5	10	11.5	13.5	16	14.56	16.39	17.63
Rate of return	1.25%	1.09%	1.17%	0.83%	0.92%	0.87%	0.98%	1.05%
EPS ²	12.1	13.6	35.3	39.9	45.6	46.76	55.55	63.46
Distribution rate	62%	73.5%	32.6%	33.8%	35.1%	31.1%	29.5%	27.8%
Net sales ¹	334,981	386,545	438,857	484,968	525,784	574,341	635,380	703,637
EBITDA ¹	84,914	103,977	116,468	129,870	150,862	163,801	186,238	210,632
EBIT ¹	64,114	82,540	91,174	104,304	125,108	136,023	157,157	181,233
Net income ¹	29,038	32,727	84,736	95,764	109,290	112,397	133,945	152,602
Net Debt ¹	-71,085	-117,366	-89,450	-162,609	-231,206	-225,994	-302,555	-397,464
Reference price ²	597.80	914.75	983.10	1,620.55	1,734.70	1,675.40	1,675.40	1,675.40
Nbr of stocks (in thousands)	2,399,335	2,399,276	2,399,276	2,399,335	2,399,335	2,399,335	-	-
Announcement Date	5/27/21	5/30/22	5/26/23	5/22/24	5/22/25	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.83x	6.61x	23.16x	0.87%	44.24B
SANDOZ GROUP AG	35.98x	3.3x	15.36x	0.98%	33.36B
OTSUKA HOLDINGS CO., LTD.	14.05x	1.77x	7.37x	1.61%	29.64B
CIPLA LIMITED	23x	3.51x	14.94x	1.06%	12.38B
ZYDUS LIFESCIENCES LIMITED	19.31x	3.34x	12.37x	0.79%	9.76B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	86.41x	-	-	1.04%	8.33B
KRKA, D. D.	17.37x	3.08x	11.32x	3.71%	7.84B
ONO PHARMACEUTICAL CO., LTD.	15.73x	1.98x	7.84x	3.47%	6.67B
GLENMARK PHARMACEUTICALS LIMITED	24.7x	3.33x	15.54x	0.13%	6.18B
Average	30.26x	3.36x	13.49x	1.52%	17.6B
Weighted average by Cap.	30.23x	3.92x	15.31x	1.27%